METHODS: Retrospective data analysis of 86 consecutive patients with MD according to current diagnostic criteria after endolymphatic sac surgery alone (ESSalone; n = 45), cochlear implantation (CI) alone (CIalone; n = 12), and ESS with CI (ESS + CI; n = 29), treated at a tertiary referral center.
METHODS: vertigo control, speech perception pre- and postoperatively.
RESULTS: Gender, side, and preoperative treatment were similar in all groups. Age was younger in the ESSalone-group with 56.2 ± 13.0 years (CIalone = 64.2 ± 11.4 years; ESS + CI = 63.1 ± 9.7 years). Definitive MD was present in all the CIalone, in 79.3% of the ESS + CI and in 59.6% of the ESSalone-patients. Likewise, vertigo control rate was 100% in the CIalone, 89.7% in the ESS + CI and 66.0% in the ESSalone-group.
CONCLUSIONS: Vertigo control was improved in all three groups, however, superior in groups treated with CI, potentially contributed by the manipulation of both the endo- and perilymphatic systems. A more systematic characterization of the patients with larger case numbers and documentation of follow up data would be needed to evaluate a clinical effect more properly.
方法:根据目前的诊断标准,对86例单纯内淋巴囊手术后的连续MD患者进行回顾性数据分析(ESSalone;n=45),单独人工耳蜗植入(CI)(CIalone;n=12),和ESS与CI(ESS+CI;n=29),在三级转诊中心接受治疗。
方法:眩晕控制,术前和术后的言语感知。
结果:性别,侧面,所有组的术前治疗相似。ESSalone组的年龄较小,为56.2±13.0岁(CIalone=64.2±11.4岁;ESSCI=63.1±9.7岁)。明确的MD存在于所有的CI中,79.3%的ESS+CI患者和59.6%的ESSalone患者。同样,仅CI的眩晕控制率为100%,ESS+CI组为89.7%,ESS单独组为66.0%。
结论:三组的眩晕控制均得到改善,然而,在接受CI治疗的组中更优,这可能是由于内淋巴系统和外淋巴系统的操纵所致。需要对病例数较大的患者进行更系统的表征,并记录随访数据,以更正确地评估临床效果。